Trial Profile
Evaluation of Safety and Efficacy of Zonisamide in Adult Patients with Partial, Generalized and Combined Seizures: An Open Labeled, Non-comparative, Observational Study Acronym: PMS Zonisamide
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Aug 2016
Price :
$35
*
At a glance
- Drugs Zonisamide (Primary)
- Indications Generalised epilepsy; Partial epilepsies
- Focus Therapeutic Use
- Acronyms PMS Zonisamide
- Sponsors Eisai Inc
- 26 Sep 2013 Interim results presented at the 21st World Congress of Neurology.
- 17 Jul 2013 Planned number of patients changed from 900 to 655 as reported by Clinical Trials Registry - India record.
- 14 Dec 2010 New trial record